Recent studies indicate that long interspersed nuclear element-1 (L1) are mobilized in the genome of human neural progenitor cells and enhanced in Rett syndrome and ataxia telangiectasia. However, whether aberrant L1 retrotransposition occurs in mental disorders is unknown. Here, we report high L1 copy number in schizophrenia. Increased L1 was demonstrated in neurons from prefrontal cortex of patients and in induced pluripotent stem (iPS) cell-derived neurons containing 22q11 deletions. Whole-genome sequencing revealed brain-specific L1 insertion in patients localized preferentially to synapse-and schizophrenia-related genes. To study the mechanism of L1 transposition, we examined perinatal environmental risk factors for schizophrenia in animal models and observed an increased L1 copy number after immune activation by poly-I:C or epidermal growth factor. These findings suggest that hyperactive retrotransposition of L1 in neurons triggered by environmental and/or genetic risk factors may contribute to the susceptibility and pathophysiology of schizophrenia.
INTRODUCTION
Mental disorders including schizophrenia, bipolar disorder, and major depression affect a large proportion of the global population and have a major negative economic impact. Twin, family, and adoption studies indicate the complex involvement of both genetic and environmental factors for these diseases (Keshavan et al., 2011) . Despite their apparent heritability, however, causative genetic factors are mostly unknown except for rare cases of schizophrenia associated with chromosomal abnormalities (Brandon and Sawa, 2011; Cook and Scherer, 2008; Karayiorgou et al., 2010) . On the other hand, environmental risk factors including prenatal infection (Brown, 2006) and obstetric complications, such as neonatal hypoxia, embryonic ischemia, and gestational toxicosis (Lewis and Murray, 1987) , are well-established risk factors for schizophrenia. However, it is not clarified how these environmental risk factors interact with genomic factors.
Accumulating evidence indicates that genomic DNA in the brain contains distinctive somatic genetic variations compared with nonbrain tissues (Poduri et al., 2013) . These genetic signatures include brain-specific somatic mutations (Poduri et al., 2013) , chromosomal aneuploidy (Rehen et al., 2005; Yurov et al., 2007) , chromosomal microdeletion (Shibata et al., 2012) , and the genome dynamics of nonlong terminal repeat (LTR) retrotransposons (Baillie et al., 2011; Evrony et al., 2012; Muotri and Gage, 2006) . These observed somatic variations are hypothesized to contribute to the generation of functionally diversified brain cells (Muotri and Gage, 2006) .
Among the known retrotransposons, only long interspersed nucleotide element-1 (L1) has autonomous retrotransposition activity. Full-length L1 elements include a 5 0 UTR, two open reading frames (ORFs), and a 3 0 UTR ( Figure 1A ). Encoded products from the ORFs contain activities required for retrotransposition and are employed in the insertion of new L1 copies as well as nonautonomous retrotransposons such as Alu and SVA (Cordaux and Batzer, 2009) . Recent studies indicate that engineered L1 has retrotransposition activity in neural progenitor cells from rat hippocampus (Muotri et al., 2005) , human fetal brain (Coufal et al., 2009) , and human embryonic stem cells (Coufal et al., 2009) . These in vitro findings were confirmed in human L1 transgenic mice in vivo (Muotri et al., 2005) . Adult human brain cells also showed increased L1 copy number compared with nonbrain tissues (Coufal et al., 2009) . Moreover, retrotransposition is active in MeCP2 mouse models and patients with Rett syndrome, indicating a role for this mechanism in this Mendelian disorder (Muotri et al., 2010) . Together, these findings suggest the Figure 1 . Increase of Brain L1 Copy Number in Schizophrenia (A) Structure of L1 and map of the primers. Primers and probes are from previous studies (Coufal et al., 2009; Muotri et al., 2010) or designed for this study (Table S4) hypothesis that L1 retrotransposition may also be involved in the pathophysiology of mental disorders.
In this study, we quantified L1 copy number in genomic DNA derived from postmortem brains of patients with major mental disorders. We report significant increases of L1 content in the prefrontal cortex of patients with schizophrenia. To confirm this finding, we quantified L1 copy number in neurons and nonneurons from a second, independent patient cohort using NeuN-based cell sorting (Iwamoto et al., 2011; Rehen et al., 2005; Spalding et al., 2005) and found that L1 copy number in neurons was increased in patients with schizophrenia. We next quantified L1 copy number in the animal models that are known to disturb early neural development. These included maternal polyriboinosinic-polyribocytidilic acid (poly-I:C) injection in mice (Meyer and Feldon, 2012; Giovanoli et al., 2013) and chronic epidermal growth factor (EGF) injection to infant macaques (Nawa et al., 2000) . We found that genomic DNA of brains from both animal models showed increased L1 copy number, addressing the importance of environmental factors during perinatal and postnatal stages. We also found that the increased L1 copy number in the neurons derived from induced pluripotent stem (iPS) cells of schizophrenia patients with 22q11 deletion. The 22q11 deletion is a well-defined genetic factor and is one of the highest risk factors for schizophrenia, affecting about 1%-2% of schizophrenia patients (Karayiorgou et al., 2010) . Finally, we performed whole-genome sequencing (WGS) analysis of brain and liver in controls and patients. Comparison of brain-specific L1 insertion sites revealed that brain-specific L1 insertion in patients is enriched in or near genes related to synaptic function and neuropsychiatric diseases. These results suggest that increased retrotransposition of L1 in neurons, which was triggered by genetic component and/or environmental factors at the early neural development, could contribute to the susceptibility and pathophysiology of schizophrenia.
RESULTS

Increased Brain L1 Content in Schizophrenia
We used postmortem prefrontal cortex samples of patients with schizophrenia, bipolar disorder, and major depression as well as control subjects for analysis in set I. The demographic variables are summarized in Figure 1B . We quantified L1 copy number of postmortem prefrontal cortex and liver in each subject by quantitative RT-PCR with two different internal controls, which were designed for human endogenous retrovirus (HERVH) and alpha-satellite (SATA). We found a significant increase in the brain L1ORF2 content in patients with schizophrenia ( Figure 1C) . A tendency toward copy number increase was also observed in mood disorders and in other L1 probes in schizophrenia (Figure S1 available online) .
Somatic L1 retrotransposition was primarily found in neuronal cells (Kuwabara et al., 2009) . To confirm the increased brain L1 copy number in schizophrenia and address whether this copy number increase is due to alteration of the neuronal genome, we examined an independent prefrontal cortex sample set (set II). We separated neuronal and nonneuronal nuclei from frozen brains using NeuN-based cell sorting ( Figure 1D ) (Iwamoto et al., 2011) . NeuN is expressed in vertebrate neurons, and its antibody can be used for labeling neuronal nuclei (Mullen et al., 1992) . We quantified L1ORF2 copy number of genomic DNA derived from neurons (NeuN-positive nuclei) and nonneurons (NeuN-negative nuclei) and then calculated the neuron-to-nonneuron ratio. We found a significant increase of neuronal L1ORF2 content in schizophrenia in two different internal controls ( Figure 1E ). The copy number of the other L1 probes tested also showed significant increase in schizophrenia compared to controls in SATA-normalized data, and similar tendency toward copy number increase was observed in HERVH-normalized data ( Figure S1 and data not shown).
Assessment of Confounding Factors
We assessed the effect of confounding factors on L1 content (Table S1) . Among the demographic variables tested, sample pH showed a weak correlation with L1ORF2 content in set II but not in set I. Several variables also showed weak correlations, but none showed consistency across the different internal control probes or across the two different sample sets.
To consider the possible effect of antipsychotics, we examined L1 copy number in a human neuroblastoma cell line cultured with haloperidol or risperidone for 8 days. Both antipsychotics did not modify the L1 copy number at their low or high concentrations ( Figure S2 ). Together with the fact that the lifetime intake of antipsychotics, which was estimated as fluphenazine milligram equivalents, did not correlate with L1 copy number in both brain sets (Table S1 ), medication status did not affect our results.
L1 Quantification in Animal Models
To assess the potential roles of environmental factors on increased L1 copy number, we employed two different animal models that mimic environmental risk factors that affect early neural development. They included maternal poly-I:C injection in mice and chronic EGF injection to neonatal macaques. The poly-I:C, which mimics viral double-stranded RNA, injection to pregnant mice induces elevated maternal immune activation, and the offspring is known to show schizophrenia-like behavioral alterations such as impairments of prepulse inhibition and social behavior at the later stage (Meyer and Feldon, 2012) . Pregnant mice received a single intraperitoneal injection of poly-I:C. L1 copy number in the prefrontal cortex of offspring was tested at postnatal day 21. We found that significant elevation of L1 copy number at all the tested probes compared to controls ( Figure 2A ).
We then examined the L1 copy number in macaques treated with EGF during neonatal period. Perinatal and postnatal 
(5s-rRNA normalized) (5s-rRNA normalized) perturbation of EGF is known to evoke schizophrenia-like phenotypes, including deficits in prepulse inhibition, latent inhibition, social interaction, and working memory, in adulthood (Nawa et al., 2009 (Nawa et al., , 2000 .The neonatal macaques (n = 2) subcutaneously received EGF for seven times over 11 days. After 4 and 7 years from treatment, L1 copy number in the prefrontal cortex was tested. In addition, chronic haloperidol-treated macaques (n = 3) were also tested. Due to unavailability of other tissues, we isolated nonneuronal nuclei from frozen white matter and calculated the grey matter-to-nonneuron ratio in each subject. Although statistical approach could not be applied, we observed increase of L1 copy number in EGF-treated macaques, but not in the haloperidol-treated macaques, compared to controls (Figure 2B) . Taken together, these results suggest that early environmental factors play important roles in the L1 content in the brain. We further confirmed that chronic haloperidol treatment did not influence L1 copy number in this model.
L1 Quantification in the iPS Cells of Schizophrenia Patients with 22q11 Deletion
We next assessed the importance of genetic risk factor on the L1 copy number in brain. We quantified L1 copy number in the neurons derived from iPS cells of schizophrenia patients with 22q11 deletion (n = 2) as well as controls (n = 2) ( Figure S3 ). The iPS cells were established from the fibroblasts according to the previously developed method (Imaizumi et al., 2012; Takahashi et al., 2007; M.T., unpublished data) . To estimate the L1 copy number, we used two independently established iPS cell lines per patient. After induction of neuronal cells (Imaizumi et al., 2012) , we isolated neuronal nuclei by NeuN-based sorting ( Figure S3 ). We then examined L1 copy number and calculated the neuron-tononneuron ratio. Compared to controls, we observed consistent increase of L1 copy number in iPS cell-derived neurons of patients with schizophrenia with 22q11 deletion (Figure 3 ). These results suggest that the well-defined strong genetic risk factor also plays an important role in the L1 content in the brain.
Identification and Comparison of Brain-Specific L1 Transposition
We next performed WGS of brain and liver DNA from same subjects by self-assembling DNA nanoarray technology (Drmanac et al., 2010) . For this experiment, schizophrenia patients (n = 3) and control subjects (n = 3) were selected to match age, PMI, gender, brain pH, and race from set I. Selected patients exhibited increased L1 content by quantitative RT-PCR assay, compared to average L1 content of the controls and selected control subjects. The WGS metrics and identified variations were summarized in Table S2 . Distribution of the detected mobile elements was almost equal between the tissues and across subjects, and over the half of the identified elements was related The comparative Ct method, with SATA as an internal control, was used. The ratio of NeuN-sorted neurons to nonneurons was calculated and then normalized relative to average value of control samples. Error bars indicate SDs. See also Table S4 and Figure S3. to the L1-Hs ( Figure S4 ). Among the detected mobile element insertion sites in each sequenced sample, we first identified brain-specific L1 insertions in each subject (Tables S2 and S3) . Although the total number of brain-specific L1 insertion tended to be higher in schizophrenia patients, this was not statistically significant, most likely due to the limited sample size and high interindividual variation. We then compared genomic locations of the insertion sites of brain-specific L1 between patients and controls ( Figure 4A ). The inter-to-intragenic L1 insertion ratio as well as exonic-to-intronic L1 insertion ratio did not differ between patients and controls. We then compared the affected genes by brain-specific L1 insertion by gene ontology approach. This analysis revealed that the number of enriched terms is higher in schizophrenia than controls, in spite that the number of brain-specific L1 insertions did not significantly differ. We found that neuronal function-related terms such as synapse and protein phosphorylation are clearly overrepresented in schizophrenia compared to controls ( Figure 4B ). In addition, diseaseassociation analysis revealed that affected genes in patients are specifically enriched in terms related to schizophrenia and bipolar disorder, while those in controls are enriched in nonneuropsychiatric terms such as height and scoliosis ( Figure 4C ). These results were consistently confirmed when we used less stringent definition of brain-specific L1 insertion ( Figure S4) addition, enrichment of the L1-inserted genes to the terms related to neuropsychiatric disorders in schizophrenia was also detected by the ingenuity pathway analysis (IPA) ( Figure S4 ).
DISCUSSION
We report that the neuronal genome of schizophrenia contains higher copy number of a retrotransposon, L1. To validate this finding, we utilized iPS cells from patients with schizophrenia carrying the 22q11 deletion and observed an increase in L1 copy number in iPS cell-derived neurons. Moreover, using WGS, we found that L1 preferentially inserted into genes related to synaptic functions and schizophrenia. Animal model studies showed that environmental factors related to infection or inflammation that disturbs early neurodevelopmental processes increase L1 copy number in the brain. Collectively, these results suggest that hyperactive L1 retrotransposition into critical genes during neural development, triggered by genetic and/or environmental factors, contribute to the pathophysiology of schizophrenia. Our results significantly expand the range of neuropsychiatric illnesses linked to aberrant L1 retrotransposition, from Mendelian disease patients with MECP2 mutations in Rett syndrome (Muotri et al., 2010) and ATM mutations in ataxia telangiectasia (Coufal et al., 2011) to schizophrenia, a complex mental disorder. The observed increase of L1 content in schizophrenia was not due to, or modulated by, biological or experimental artifacts, because changes were measured in two independent patient cohorts and each result was confirmed with two different internal controls. Although the L1 region showing significant increases differed between the two brain sets, this is attributable to cohort differences amplified by the strict threshold we employed. Actually, a significant increase of L1 content was widely observed in all probes in the SATA-normalized data in set II, where neuronal L1 copy number was directly examined ( Figure S1 ). In addition, from the data analysis utilizing lifetime intake of antipsychotics of patients, and from the cell culture and macaque experiments, we conclude that antipsychotics do not affect L1 copy number in the brain. A significant increase was also observed in patients with mood disorders in one internal control in set I ( Figure 1C) . Future work will clarify whether there are L1 content increases in other mental disorders using larger and/or stratified patient cohorts.
L1 retrotransposition has been detected during adult neurogenesis in the rat hippocampus, indicating that neural progenitor cells retain retrotransposition activity even in adult stages ). However, we analyzed potential confounding factors, including age, age of onset, and duration of illness, and did not observe any significant correlation with L1 copy number in the brain. The transcript level of L1 in adult brain sample was also increased in patients compared to controls (data not shown). However, elevated expression is unlikely to contribute to increase of L1 copy number in patients, as significant increase of L1 transcripts was detected only in the 5 0 region of L1 such as 5 0 UTR and ORF1. These results suggest that L1 copy number does not globally increase with aging and that the variation of L1 copy number in patients is probably confined to early neurodevelopmental stages, at least in the prefrontal cortex. This prediction would be consistent with the neurodevelopmental hypothesis of schizophrenia, where abnormalities during critical early periods of brain development may trigger the later appearance of clinical symptoms (Bloom, 1993; Murray et al., 1992; Weinberger, 1987) . In Rett syndrome, increased L1 copy number in human brain was linked to mutations in MECP2 (Muotri et al., 2010) and MeCP2 knockout mice also showed increased L1 content (Muotri et al., 2010) . It has also been suggested that SOX2 and MECP2 regulate L1 transcription in neurons (Muotri et al., 2005; Yu et al., 2001 ). However, we did not observe a significant correlation between MECP2 or SOX2 expression and brain L1 content, by using the previously performed gene expression analyses on the same sample sets (Iwamoto et al., 2004 (Iwamoto et al., , 2005 (data not shown). In addition, patients with high levels of L1 copy number (two schizophrenia and one major depression in set I, and two schizophrenia patients in set II) did not show altered MECP2 or SOX2 expression levels (data not shown). These findings suggest that the molecular mechanism of increased L1 in schizophrenia is different from Rett syndrome.
In this study, we found that both early environmental and welldefined strong genetic factors for schizophrenia are involved in the increase of L1 copy number in the brain. A recent study using the poly-I:C model indicated that the offspring of this model had exacerbated schizophrenia-like phenotypes, if they were exposed to environmental stress during puberty, suggesting that early environmental factors can lower the threshold for onset of schizophrenia (Giovanoli et al., 2013) . Therefore, increased L1 insertions induced by environmental factors may increase the susceptibility to schizophrenia by disrupting synaptic and schizophrenia-related genes in neurons, rather than being a direct cause of the disease. On the other hand, the pathological consequences of increased L1 content in neurons derived from iPS cells of schizophrenia patients with 22q11 deletions remain unclear. We chose patients with 22q11 deletions to examine L1 dynamics where there is a well-defined strong genetic risk for schizophrenia. In MeCP2-knockout mice, Rett-like behavioral abnormalities could be rescued by the re-expression of wildtype MeCP2 at both young and adult stages (Cobb et al., 2010; Ehninger et al., 2008) , suggesting that L1 content itself may not be directly causal to disease phenotypes but instead modulate phenotypic variability among patients (Muotri et al., 2010) . Similarly, we speculate that the L1 increase in schizophrenia patients with 22q11 deletions is likely to modulate phenotypes of schizophrenia rather than a direct cause, because many genes related to schizophrenia, such as TBX-1, SEPT5, COMT, and PRODH, are located within the deletion (Hiroi et al., 2013; Karayiorgou et al., 2010) . Nevertheless, our findings will facilitate further studies of the mechanism of increased L1 retrotransposition associated with schizophrenia.
Our WGS analysis could not detect increased brain-specific L1 insertions in schizophrenia; however, we found that L1 insertions were more frequent in genes for synaptic function and schizophrenia relative to controls. Evrony et al. cloned one L1 insertion event from 300 single neurons and showed that 2 of 83 cortical neurons from an individual had this insertion, but detection of such a low level mosaic insertion in bulk brain tissue of the same individual was difficult and needed optimization (Evrony et al., 2012 ). Thus, rare L1 insertion events could be missed in our WGS analysis. Apart from L1, nonautonomous retrotransposons such as Alu and SVA also show an increased copy number in the brain, possibly via the aid of L1 ORF products (Baillie et al., 2011) and their copy number might also be increased in patients. Further studies on the neuronal genome of patients with mental disorders, and supporting mechanistic evidence from animal and cellular models, may establish a broader role for instability of neural genome in the pathophysiology of schizophrenia. We expect that our findings will promote the further study of genomic instability in disease etiology due to L1 retrotransposition in brain development.
EXPERIMENTAL PROCEDURES
Postmortem Samples Postmortem brain and liver samples were obtained from the Stanley Medical Research Institute. The demographics are summarized in Figure 1B and are described at the web site (http://www.stanleyresearch.org/). Ethics committees of RIKEN and the University of Tokyo Faculty of Medicine approved the study.
Animal Models
Animal experiments were performed in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals and guidelines of relevant facilities. For poly I:C model, pregnant mice (C57BL/6) received either a single intraperitoneal injection of poly-I:C (2 mg/ml, Sigma-Aldrich) dissolved in PBS (20 mg/kg) or an equivalent volume of PBS at embryonic day 9.5. At postnatal day 21, tissues were dissected from pups. For macaque models, cynomologus monkeys (Macaca fascicularis) (4 years old; all males) were given oral haloperidol (0.25-0.5 mg/kg; Wako Pure Chemical Industries) or vehicle for 2 months (Shibuya et al., 2010) . After transiently separating two male monkey neonates (2 weeks old) from dams, neonates received subcutaneous administration of human recombinant EGF (0.3 mg/kg, Funakoshi) for seven times over 11 days and then quickly returned to their dams. Preliminary behavioral assessment of the EGF-treated monkeys was performed at ages of 4 and 6 years and reported (Nawa et al., 2009 ). These monkeys were sacrificed at the age of 4 and 7 years with the overdose of pentobarbital (26 mg/kg; 65 mg/ml). Experiments were subjected to review by the Ethical Committee of Shinn Nippon Biomedical Lab.
iPS Cells All procedures for skin biopsy and iPS cell production were approved by the Keio University School of Medicine ethics committee and RIKEN ethics committee. The 201B7 iPS cells were kindly provided by Dr. Yamanaka (Takahashi et al., 2007) . For the control WD39, a skin-punch biopsy from a healthy 16-year-old Japanese female obtained after written informed consent was used to generate iPS cells (Imaizumi et al., 2012) . 22q11.2 deletion syndrome iPS cells (SA001 and KO001) were generated from a 37-year-old Japanese female patient (Toyosima et al., 2011) and a 30-year-old Japanese female patient, respectively, using the same method used to generate the WD39 (M.T., unpublished data). 22q11 deletion was characterized by the CGH array analysis ( Figure S3 ). Production and maintenance of iPS cells were performed according to the previous studies (Imaizumi et al., 2012; Takahashi et al., 2007) . All the iPS cells and differentiated neuronal cell lines were characterized with immunofluorescence staining and their morphologies ( Figure S3 ).
L1 Copy Number Estimation
We performed either Taqman-based quantitative real-time PCR according to Coufal et al. (2009) with minor modifications (100 or 500 pg DNA as starting material and single amplicon analysis) or SYBR-Green-based quantitative real-time PCR according to Muotri et al. (2010) . SYBR-Green assay was performed using 500 pg DNA and Power SYBR Green PCR Master Mix (Life Technologies). Primers, probe location, and reaction chemistry are listed in Figure 1A and Table S4 . Quantification was performed in triplicate. A nonparametric Mann-Whitney U test was employed for two group comparison and p < 0.05 was considered significant.
Whole-Genome Sequencing WGS of brain and liver samples from controls and schizophrenia patients was performed by Complete Genomics, with the paired-end library preparation and sequencing-by-ligation using self-assembling DNA nanoball (DNB) (Drmanac et al., 2010) . Data process, mapping, and detection of variations were performed using the software developed by the Complete Genomics (version 2.2.0.26 and format version 2.2). Among the detected mobile insertion elements, we compared the genomic location of L1 insertion between brain and liver within an individual and identified brain-specific L1 insertions.
Further experimental details are available in the Supplemental Experimental Procedures.
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